Randomized controlled pilot study of the clinical efficacy of the Mika App

Randomized controlled pilot study of the clinical efficacy of the Mika App - MIKA

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023791

Enrollment

Registered

2022-02-24

Start date

2020-06-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C51-C58

Interventions

Group 1: Intervention group receives Mika over a period of 12 weeks Group 2: Control group receives treatment as ususal

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: possession of a smartphone - diagnosed carcinoma (ovary, endometrium, cervix) - German speaking

Exclusion criteria

Exclusion criteria: - no secured diagnosis of carcinoma - not able to give informed consent - diagnosis more than 5 years ago -lack of smartphone or tablet skills

Design outcomes

Primary

Measure	Time frame
Group comparison of change in psychological distress, measured by the PHQ-9, from baseline (week 0) to week 12 between.	—

Secondary

Measure	Time frame
Group comparison of change in fatigue symptomatology (measured with EORTC-QLQ-C30) and health literacy (measured with HLS-EU-Q16) from baseline to week 12.	—

Countries

Germany

Contacts

Public ContactAyline Maier

Fosanis GmbH

AylineM@web.de+491784114659

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 10, 2026